Target intelligence / Profile preview

HAUS complex subunit 3–DNA polymerase nu readthrough protein (null)

Target
null
Molecular classification
Readthrough fusion protein, Other (no canonical molecular classification such as receptor, enzyme, transporter, ion channel, etc.; structural/family classification unclear)
01

Overview

This protein is the product of translational readthrough, where the ribosome bypasses a canonical stop codon to continue translating across adjacent open R\nreading frames of HAUS3 and POLN. Readthrough proteins can occur infrequently due to regulatory or sequence elements in mRNA[2][3][6]. Such fusion products may retain partial functions of their parental proteins—HAUS3 (a component involved in microtubule organization) and POLN (a specialized DNA polymerase involved in DNA repair)—but the specific structure, function, and physiological relevance of the HAUS3-POLN readthrough protein have not been established in the literature. There is no evidence for its therapeutic relevance or implications in human disease; its existence is annotated through bioinformatic prediction and ribosome profiling, not biochemical validation[2][6].

Other names
HAUS3-POLN readthrough proteinENSG00000290263HAUS Augmin-like complex subunit 3–DNA polymerase nu readthrough
02

Mechanism of action

null

03

Biological functions

Potential effects related to microtubule organization (HAUS3-related, component of Augmin complex)[1]DNA repair or translesion DNA synthesis (POLN-related, DNA polymerase activity)[1]Other (no experimental data for the fusion protein itself; inferred from source gene functions)
04

Disease associations

Other (no direct disease association or roles established for this protein; possible indirect relevance only via source gene pathways)

Beyond the preview

Go deeper on HAUS complex subunit 3–DNA polymerase nu readthrough protein (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HAUS complex subunit 3–DNA polymerase nu readthrough protein (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call